Spectral AIMDAI
About: Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
Employees: 78
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
164% more capital invested
Capital invested by funds: $3.6M [Q3] → $9.53M (+$5.92M) [Q4]
100% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 5
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
22% more funds holding
Funds holding: 23 [Q3] → 28 (+5) [Q4]
1.61% less ownership
Funds ownership: 17.53% [Q3] → 15.92% (-1.61%) [Q4]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Swayampakula Ramakanth 0% 1-year accuracy 0 / 7 met price target | 171%upside $3.50 | Buy Reiterated | 2 Apr 2025 |
Financial journalist opinion
Based on 6 articles about MDAI published over the past 30 days









